In my professional experience working with high-performance liquid chromatography (HPLC), selecting the right stationary phase is critical for achieving reproducible results. The BIOshell A160 Peptide C18 has become a staple in my laboratory AdvanceBio Peptide Plus Reversed-Phase Columns for ro BIOshell ™ A160 Peptide C18 (2 µm) HPLC Columns utine analytical tasks. When evaluating BIOshell A160 Peptide C18 columns, the focus is often on the Fused-Core® technology, which provides the high efficiency required for complex sample matrices.
Technical Specifications and Engineering
The A160 Peptide C18 is engineered with a 160 Å pore size, which is specifically designed to facilitate the mass transfer of larger molecules. Whether I am using the 2.7 µm or the 2.0 µm particle size, the BIOshell A160 Peptide C18 consistently demonstrates excellent peak shape. The Specifications of these columns—often housed in robust stainless steel hardware—ensure they can withstand the rigors of high-pressure liquid chromatography (UHPLC) environments.
When comparing this to a Biozen Peptide PS C18 column or a Biozen Peptide XB-C18, I find that the BIOshell series offers a distinct balance of pressure and resolution. The A160 Peptide chemistry is particularly effective when working with peptides that exhibit varying degrees of hydrophobicity.
Application in Analytical Chemistry
In my lab, we frequently handle samples that are ideal for tryptic digests, post-translational modifications (PTMs), and polypeptides. The C18 bonded phase is the gold standard for these applications because the peptides bind effectively in high-aqueous mobile phases.
Often, I am asked about the difference between BIOshell A160 Peptide C18 and the BIOSHELL A160 PEPTIDE CN. While the C18 phase provides the non-polar retention mechanism necessary for most revers The HALO® 160 Å ES C18 column for peptide separations is ideal for tryptic digests, post-translational modifications (PTMs), polypeptides. Buy it here. ed-phase workflows, the CN phase offers an alternative selectivity. Both are reversed-phase, C18 HPLC columns (or derivatives thereof) that utilize core-shell technology to minimize diffusion paths.
Why Core-Shell Technology Matters
Many modern columns, including those that use core-shell XB-C18 chemistry, aim to achieve the performance of sub-2 µm particles without the extreme backpressure issues associated with totally porous particles. The BIOshell A160 Peptide utilizes this exact principle. It is similar in design philosophy to Poroshell 120 core-shell mixed-mode C18 particles, which are also widely recognized for their ability to deliver sharp peaks and Biozen Peptide XB-C18 allows for fast and effective elution windows by utilizing core-shell particles to gain sharper peaks, better peak capacities, and overall high peak capacity.
Personal Insights on Selection
Choosing between a Bioshell column and other manufacturers often comes down to the specific length and internal diameter (I.D.) required for the in Biozen-Peptide-PS-C18 tegration. I have found that:
* 2.0 µm particles are superior for fast, high-resolution UHPLC separations.
* 2.7 µm particles offer AdvanceBio Peptide Plus Reversed-Phase Columns a versatile middle ground for standard HPLC systems.
* 5.0 µm particles remain reliable for older systems or specific preparative applications where flow rate constraints exist.
Whether you are performing routine peptide mapping or complex peptide quantitation, the BIOshell A160 Peptide C18 remains a high-performance, reliable choice. By maintaining proper care and following the manufacturer's usage guidelines, these columns provide the longevity and reproducibility required for high-stakes analytical environments. In my personal review, the structural integrity of the BIOshell A160 Peptide C18 columns makes them an essential asset in any modern chromatography setup.